Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

Subjects:

a) FB image processing featuring (1) FB map, (2) TWOMBLI mask, (3) FB-mask multiplied image, and (4) Ridge detection selection of contours. b) TWOMBLI Output Descriptions. (1) Area... by Zoë Dinkel (21402766)

Changes of muscle oxygen saturation. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

Coupling coordination degree results. by Jie Huang (104235)

“…Spatially, the CCD demonstrates a characteristic pattern of decreasing from east to west. Overall, achieving a “cross-level transition” in CCD is challenging, and the neighboring provinces significantly influence the enhancement of local CCD. …”

Change in the ERCC1 secretion level in plasma(pg/ml). by Hao Deng (409186)

Comparison of serum VEGF-A165 concentrations pre-bevacizumab administration in patients with increased VEGF-A post-bevacizumab administration and those with decreased VEGF-A. by Masashi Okawa (8951294)

Subjects:

Equivalent effect model. by Xueting Ma (390540)

Subjects:

Simulation model. by Xueting Ma (390540)

Subjects:

Displacement of soil particles in z direction. by Xueting Ma (390540)

Subjects:

Simulation parameters [13]. by Xueting Ma (390540)

Subjects:

Displacement of soil particles in x direction. by Xueting Ma (390540)

Subjects:

Soil particle simulation model. by Xueting Ma (390540)

Subjects:

Multi-factor experimental results. by Xueting Ma (390540)

Subjects:

Frequency-displacement curve. by Xueting Ma (390540)

Subjects:

Bonding bonds between soil particles. by Xueting Ma (390540)

Subjects:

Test factor coding. by Xueting Ma (390540)

Subjects:

Displacement of soil particles in y direction. by Xueting Ma (390540)

Subjects:

Frame structure and key dimensions. by Xueting Ma (390540)

Subjects:

Summary of significant treatment × time effect. by Wensheng Xiao (16557866)